ReCode Therapeutics, a clinical-stage genetic medicines company using lipid nanoparticle delivery to power the next wave of mRNA and gene correction therapeutics, today announced a series of updates ...
SAN DIEGO, CA, UNITED STATES, August 4, 2026 /EINPresswire.com/ -- Key Takeaways ï‚·Investigational New Drug (IND) ...
CREATE Medicines, Inc. ("CREATE"), a clinical-stage biotechnology company pioneering in vivo immune programming, today announced a strategic research collaboration with Australia's Monash University ...
A study revealed that early membrane lipid organization, controlled by a key protein, directs germ cell formation and helps ...
Origin of life researchers at Hebrew University show that fatty acids and hydroxy acids, when chemically bonded, form hybrid ...
Cells sitting side by side in the same tissues are not identical. Each cell carries its own subtly different chemical signature—a hidden individuality that can reveal how diseases take root and spread ...
Nanoparticle coatings can come loose in the body, causing therapies to miss their target or trigger side effects. The development and subsequent approval of SARS-CoV-2 mRNA vaccines saved countless ...
The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever and general malaise. Those symptoms, which typically resolve within days, are the natural ...
Postdoctoral fellow and co-first author Dongyoon Kim demonstrates some of the equipment used to craft the new ionizable lipids. [Bella Ciervo, Penn Engineering] The explosion of mRNA vaccines brought ...
Effective delivery strategies are vital for message RNA (mRNA) vaccines and therapeutics, with lipid nanoparticles (LNPs) being forefront. Developing ionizable lipids, a key LNP component, ...